{
    "startDate": "2021-01-01",
    "endDate": "2021-12-31",
    "year": "2021",
    "quarter": "FY",
    "symbol": "SYN",
    "data": {
        "bs": [
            {
                "label": "Total Liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4957000
            },
            {
                "label": "Commitments and Contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 336560000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -271284000
            },
            {
                "label": "Series B Preferred Stock, $1,000 par value; 10,000,000 shares authorized, 0 issued and outstanding and 3,973 issued and outstanding as of September 30, 2021 and December 31, 2020, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued employee benefits",
                "concept": "AccruedEmployeeBenefitsCurrent",
                "unit": "usd",
                "value": 978000
            },
            {
                "label": "Total Stockholders' Equity (Deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 65408000
            },
            {
                "label": "Total Stockholders' Equity (Deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 65408000
            },
            {
                "label": "Deposits and other assets",
                "concept": "syn:DepositsAndOtherAssetsNoncurrent",
                "unit": "usd",
                "value": 23000
            },
            {
                "label": "Series A Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 and 120,000 issued and outstanding as of September 30, 2021 and December 31, 2020, respectively",
                "concept": "TemporaryEquityCarryingAmountAttributableToParent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value; 200,000,000 shares authorized, 132,044,866 issued and 132,042,538 outstanding at September 30, 2021 and 29,252,253 issued and 29,249,925 outstanding at December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 132000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1533000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1533000
            },
            {
                "label": "Total Current Liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3554000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 67325000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 67300000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 524000
            },
            {
                "label": "Total Current Assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 68858000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1928000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1928000
            },
            {
                "label": "Lease liability - long term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1403000
            },
            {
                "label": "Lease liability - long term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1403000
            },
            {
                "label": "Right of use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1383000
            },
            {
                "label": "Total Synthetic Biologics, Inc. and Subsidiaries Equity (Deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 65408000
            },
            {
                "label": "Total Liabilities and Stockholders' Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 70365000
            },
            {
                "label": "Lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 124000
            },
            {
                "label": "Lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 124000
            },
            {
                "label": "Total Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 70365000
            }
        ],
        "cf": [
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -363000
            },
            {
                "label": "Right of use asset",
                "concept": "syn:IncreaseDecreaseRightOfUseAssets",
                "unit": "usd",
                "value": 166000
            },
            {
                "label": "Effect of Warrant exercise price adjustment",
                "concept": "syn:WarrantExercisePriceAdjustment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Effect of Warrant exercise price adjustment",
                "concept": "syn:WarrantExercisePriceAdjustment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deemed dividends for accretion of Series B Preferred Stock discount",
                "concept": "syn:DeemedDividendsWithBeneficialConversionFeature",
                "unit": "usd",
                "value": 1496000
            },
            {
                "label": "Proceeds from \"at the market\" stock issuance",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 65960000
            },
            {
                "label": "Subsidiary stock issuances to vendor",
                "concept": "syn:SubsidiaryStockIssuesToVendor",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1004000
            },
            {
                "label": "Return of SYN Biomics Stock",
                "concept": "syn:ReturnOfSynBiomicsStock",
                "unit": "usd",
                "value": 2774000
            },
            {
                "label": "Net Cash Used in Operating Activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -12890000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net Cash Used in Investing Activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -14000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 61098000
            },
            {
                "label": "In-kind dividends paid in preferred stock",
                "concept": "DividendsPreferredStockPaidinkind",
                "unit": "usd",
                "value": 24000
            },
            {
                "label": "Net Cash Provided by Financing Activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 74002000
            },
            {
                "label": "Preferred stock price adjustment",
                "concept": "syn:PreferredStockPriceAdjustment",
                "unit": "usd",
                "value": 7402000
            },
            {
                "label": "Proceeds from issuance of common stock for warrant exercises",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 8042000
            },
            {
                "label": "Proceeds from issuance of common stock for warrant exercises",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 8000000.0
            },
            {
                "label": "Right of use assets from operating lease",
                "concept": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
                "unit": "usd",
                "value": 1270000
            },
            {
                "label": "Accrued employee benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": 110000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -174000
            },
            {
                "label": "Lease liability",
                "concept": "syn:IncreaseDecreaseLeaseLiability",
                "unit": "usd",
                "value": -216000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 14000
            },
            {
                "label": "Depreciation",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 87000
            },
            {
                "label": "Depreciation",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 87000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 416000
            }
        ],
        "ic": [
            {
                "label": "Total Other Income",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 6000
            },
            {
                "label": "Net Loss Per Share - Basic",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.19
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 6474000
            },
            {
                "label": "Net Loss Attributable to Non-controlling Interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Weighted average number of shares outstanding during the period - dilutive",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 121875042
            },
            {
                "label": "Loss from Operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -14274000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 6000
            },
            {
                "label": "Net Loss Per Share - Dilutive",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.19
            },
            {
                "label": "Net Loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net Loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net Loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -14268000
            },
            {
                "label": "Net Loss Attributable to Synthetic Biologics, Inc. and Subsidiaries",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -14267000
            },
            {
                "label": "Net Loss Attributable to Common Stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -23189000
            },
            {
                "label": "Weighted average number of shares outstanding during the period - basic",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 121875042
            },
            {
                "label": "Effect of Series A Preferred Stock Price adjustment",
                "concept": "syn:PreferredStockPriceAdjustment",
                "unit": "usd",
                "value": 7402000
            },
            {
                "label": "Total Operating Costs and Expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 14274000
            },
            {
                "label": "Effect of Warrant exercise price adjustment",
                "concept": "syn:WarrantExercisePriceAdjustment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Effect of Warrant exercise price adjustment",
                "concept": "syn:WarrantExercisePriceAdjustment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 7800000
            }
        ]
    }
}